APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gastro Esophageal Reflux Disease (GERD) Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastro Esophageal Reflux Disease (GERD) Drug Industry Growth and Trends Forecast to 2032

Report ID 173994180126 December 2025105 pages

Choose your research edition.

Industry ResearchGastro Esophageal Reflux Disease (GERD) Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastro Esophageal Reflux Disease (GERD) Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug include Addex Therapeutics, Aros Pharma, AstraZeneca, Plc., Medtronic, Takeda Pharmaceutical Company Limited, The Kroger Co., GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastro Esophageal Reflux Disease (GERD) Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastro Esophageal Reflux Disease (GERD) Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastro Esophageal Reflux Disease (GERD) Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastro Esophageal Reflux Disease (GERD) Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gastro Esophageal Reflux Disease (GERD) Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastro Esophageal Reflux Disease (GERD) Drug Market by Company

Addex Therapeutics

Aros Pharma

AstraZeneca, Plc.

Medtronic

Takeda Pharmaceutical Company Limited

The Kroger Co.

GlaxoSmithKline

Pfizer

Merck

Novartis AG

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type

H2 Receptor Antagonist

Proton Pump Inhibitor (PPi)

Antacids

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application

Clinic

Hospital

Medical Center

Others

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastro Esophageal Reflux Disease (GERD) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastro Esophageal Reflux Disease (GERD) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastro Esophageal Reflux Disease (GERD) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastro Esophageal Reflux Disease (GERD) Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gastro Esophageal Reflux Disease (GERD) Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of H2 Receptor Antagonist Table 2. Major Company of Proton Pump Inhibitor (PPi) Table 3. Major Company of Antacids Table 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends Table 26. Gastro Esophageal Reflux Disease (GERD) Drug Industry Drivers Table 27. Gastro Esophageal Reflux Disease (GERD) Drug Industry Opportunities and Challenges Table 28. Gastro Esophageal Reflux Disease (GERD) Drug Industry Restraints Table 29. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Company (2021-2026) Table 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Company (2021-2026) Table 33. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Gastro Esophageal Reflux Disease (GERD) Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Gastro Esophageal Reflux Disease (GERD) Drug Major Company Production Sites and Headquarters Table 36. Global Gastro Esophageal Reflux Disease (GERD) Drug Company, Product Type & Application Table 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Gastro Esophageal Reflux Disease (GERD) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Addex Therapeutics Company Information Table 73. Addex Therapeutics Business Overview Table 74. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 76. Addex Therapeutics Recent Development Table 77. Aros Pharma Company Information Table 78. Aros Pharma Business Overview Table 79. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 81. Aros Pharma Recent Development Table 82. AstraZeneca, Plc. Company Information Table 83. AstraZeneca, Plc. Business Overview Table 84. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 86. AstraZeneca, Plc. Recent Development Table 87. Medtronic Company Information Table 88. Medtronic Business Overview Table 89. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 91. Medtronic Recent Development Table 92. Takeda Pharmaceutical Company Limited Company Information Table 93. Takeda Pharmaceutical Company Limited Business Overview Table 94. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 96. Takeda Pharmaceutical Company Limited Recent Development Table 97. The Kroger Co. Company Information Table 98. The Kroger Co. Business Overview Table 99. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 101. The Kroger Co. Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 111. Pfizer Recent Development Table 112. Merck Company Information Table 113. Merck Business Overview Table 114. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 116. Merck Recent Development Table 117. Novartis AG Company Information Table 118. Novartis AG Business Overview Table 119. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 121. Novartis AG Recent Development Table 122. North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 124. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2026) Table 125. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Country (2027-2032) Table 127. North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country (2021-2026) Table 130. North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Country (2027-2032) Table 132. Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 134. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2026) Table 135. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country (2021-2026) Table 140. Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country (2021-2026) Table 150. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Country (2027-2032) Table 152. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 154. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2026) Table 155. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country (2021-2026) Table 160. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country (2021-2026) Table 170. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List Table 175. Gastro Esophageal Reflux Disease (GERD) Drug Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Image Figure 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (2021-2032) & (K Units) Figure 5. H2 Receptor Antagonist Image Figure 6. Global H2 Receptor Antagonist Sales YoY Growth (2021-2032) & (K Units) Figure 7. Proton Pump Inhibitor (PPi) Image Figure 8. Global Proton Pump Inhibitor (PPi) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Antacids Image Figure 10. Global Antacids Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Type 2025 VS 2032 Figure 13. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Gastro Esophageal Reflux Disease (GERD) Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Medical Center Image Figure 30. Global Medical Center Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Application 2025 VS 2032 Figure 35. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Gastro Esophageal Reflux Disease (GERD) Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Receptor Antagonist
  • Proton Pump Inhibitor (PPi)
  • Antacids
Applications
  • Clinic
  • Hospital
  • Medical Center
  • Others
Companies covered
  • Addex Therapeutics
  • Aros Pharma
  • AstraZeneca, Plc.
  • Medtronic
  • Takeda Pharmaceutical Company Limited
  • The Kroger Co.
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gastro Esophageal Reflux Disease (GERD) Drug Market by Type
  6. 1.3.1 H2 Receptor Antagonist
  7. 1.3.2 Proton Pump Inhibitor (PPi)
  8. 1.3.3 Antacids
  9. 1.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type
  10. 1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends
  2. 2.2 Gastro Esophageal Reflux Disease (GERD) Drug Industry Drivers
  3. 2.3 Gastro Esophageal Reflux Disease (GERD) Drug Industry Opportunities and Challenges
  4. 2.4 Gastro Esophageal Reflux Disease (GERD) Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Gastro Esophageal Reflux Disease (GERD) Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Gastro Esophageal Reflux Disease (GERD) Drug Price (2021-2026)
  4. 3.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Gastro Esophageal Reflux Disease (GERD) Drug Company, Product Type & Application
  7. 3.7 Global Gastro Esophageal Reflux Disease (GERD) Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastro Esophageal Reflux Disease (GERD) Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastro Esophageal Reflux Disease (GERD) Drug Tier 1, Tier 2, and Tier 3
4 Gastro Esophageal Reflux Disease (GERD) Drug Regional Status and Outlook
  1. 4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size by Region
  3. 4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Region
  7. 4.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gastro Esophageal Reflux Disease (GERD) Drug by Application
  1. 5.1 Gastro Esophageal Reflux Disease (GERD) Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Medical Center
  5. 5.1.4 Others
  6. 5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application
  7. 5.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Addex Therapeutics
  2. 6.1.1 Addex Therapeutics Company Information
  3. 6.1.2 Addex Therapeutics Business Overview
  4. 6.1.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  6. 6.1.5 Addex Therapeutics Recent Developments
  7. 6.2 Aros Pharma
  8. 6.2.1 Aros Pharma Company Information
  9. 6.2.2 Aros Pharma Business Overview
  10. 6.2.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  12. 6.2.5 Aros Pharma Recent Developments
  13. 6.3 AstraZeneca, Plc.
  14. 6.3.1 AstraZeneca, Plc. Company Information
  15. 6.3.2 AstraZeneca, Plc. Business Overview
  16. 6.3.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  18. 6.3.5 AstraZeneca, Plc. Recent Developments
  19. 6.4 Medtronic
  20. 6.4.1 Medtronic Company Information
  21. 6.4.2 Medtronic Business Overview
  22. 6.4.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  24. 6.4.5 Medtronic Recent Developments
  25. 6.5 Takeda Pharmaceutical Company Limited
  26. 6.5.1 Takeda Pharmaceutical Company Limited Company Information
  27. 6.5.2 Takeda Pharmaceutical Company Limited Business Overview
  28. 6.5.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  30. 6.5.5 Takeda Pharmaceutical Company Limited Recent Developments
  31. 6.6 The Kroger Co.
  32. 6.6.1 The Kroger Co. Company Information
  33. 6.6.2 The Kroger Co. Business Overview
  34. 6.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  36. 6.6.5 The Kroger Co. Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Merck
  50. 6.9.1 Merck Company Information
  51. 6.9.2 Merck Business Overview
  52. 6.9.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  54. 6.9.5 Merck Recent Developments
  55. 6.10 Novartis AG
  56. 6.10.1 Novartis AG Company Information
  57. 6.10.2 Novartis AG Business Overview
  58. 6.10.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  60. 6.10.5 Novartis AG Recent Developments
7 North America by Country
  1. 7.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
  2. 7.1.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  6. 7.2.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
  2. 8.1.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  6. 8.2.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
  2. 9.1.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
  2. 10.1.1 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  6. 10.2.1 South America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
  2. 11.1.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gastro Esophageal Reflux Disease (GERD) Drug Value Chain Analysis
  2. 12.1.1 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process
  7. 12.2 Gastro Esophageal Reflux Disease (GERD) Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors
  10. 12.2.3 Gastro Esophageal Reflux Disease (GERD) Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst